FDA Warns GSK Over Manufacturing Violations In UK
During a routine inspection in March, FDA officials uncovered significant violations of manufacturing regulations at SmithKline Beecham Ltd.'s plant in Worthing, West Sussex, according to the letter.
"These violations cause your drug products to be adulterated," the FDA's Oct. 7 letter said.
The only product the Worthing plant exports to the U.S....
To view the full article, register now.